GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver ...

Migraines are a common ailment worldwide, affecting nearly 15% of the global population. At times, they can be debilitating ...

You've heard about the likes of Ozempic, Wegovy and Mounjaro, jabs which a growing number of people are taking in an attempt ...

A Chinese company has developed a new diabetes drug that could become a strong competitor to Ozempic and Monjauro as a weight ...

People with unresponsive chronic migraine and obesity experienced substantial relief after they started taking a GLP-1 drug, ...

Refusing the subscription would be a good test of the friendship. If it continues, your friend is friends with you for who ...

Diabetics are more likely to develop Alzheimer’s than the general public. Could a popular diabetes and weight-loss drug also stave off dementia?

A novel medication out of Sweden has shown some of the same promise in melting belly fat — without making your stomach churn.

The active ingredient in Ozempic was associated with a reduced risk of Alzheimer's disease-related dementia among diabetes ...

Having to take Ozempic or other weight loss drugs can be a real pain in the ass, with users often having to jab themselves ...

A new weight loss pill currently undergoing clinical trials could help burn fat and lower blood sugar levels like Ozempic and ...

In a paper released in Addiction, scientists reported that people with a history of alcohol use disorder who were prescribed ...